DEA Deschedules Epidiolex, Senators Urge SBA to Extend Economic Assistance to Cannabis Businesses: Week in Review

Cannabis Business Times
Apr 11, 2020, 8:30 am318 pts
This week, the U.S. Drug Enforcement Administration (DEA) descheduled GW Pharmaceuticals’ Epidiolex, an anti-epileptic drug that contains cannabidiol (CBD). Elsewhere, a coalition of U.S. senators sent a letter to leadership asking that cannabis businesses qualify for loans and other federal relief programs…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Rhode Island Marijuana Dispensary License Application Process Officially Launches 71

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.